MetLife, Inc. (MET)

Over the past six months, MetLife's stock price has fluctuated, with a 52-week high of $83.85 on December 16, 2025, and a 52-week low of $67.33 on March 27, 2026. The company's Q4 2025 financial results, released in February 2026, showed adjusted EPS of $2.58, surpassing expectations, but total revenue of $23.81 billion missed forecasts due to net derivative losses. Broader financial sector weakness and macroeconomic concerns have also impacted MetLife's stock performance. In April 2026, analysts from Evercore ISI and UBS raised their price targets for MetLife. In December 2024, MetLife unveiled its "New Frontier" growth strategy, aiming for double-digit adjusted earnings per share growth and a 15-17% adjusted return on equity over the next five years.

The available information does not indicate a prominent or clearly defined demand seasonality for MetLife's broad range of insurance products and financial services. The demand for MetLife's core offerings appears to be more continuous, and the company focuses on consistent demand through a diversified product portfolio and strategic initiatives.

MetLife, Inc. is a global financial services company offering insurance, annuities, employee benefits, and asset management services to individual and institutional clients. It operates in the Financial Services sector, specifically in the Life & Health Insurance and Multi-line Insurance industries. MetLife's products include life insurance, annuities, and employee benefits, along with financial services like financial planning, retirement planning, and asset management.

MetLife, Inc. has a significant global presence, operating in more than 40 markets worldwide. It holds leading market positions in key regions including the United States, Japan, Latin America, Asia, Europe, the Middle East, and Africa. Specific countries where MetLife has a strong presence include Mexico, Japan, South Korea, Bangladesh, and Chile.

MetLife has maintained a strong brand reputation over the past year, receiving several prestigious recognitions. For the seventh consecutive year, MetLife was named on the Fortune World's Most Admired Companies™ list, ranking No. 1 in the Insurance: Life and Health industry for 2026. MetLife was recognized for the second consecutive year on the Fortune World's 25 Best Workplaces™ list in 2025, ranking No. 10. The company also achieved certification as a Great Place to Work in 33 markets globally and was named one of the Fortune 100 Best Companies to Work For in the U.S. for the fourth consecutive year.

MetLife's ownership is primarily dominated by institutional investors, who collectively hold approximately 74.95% of the company's stock. Key institutional shareholders include Vanguard Group Inc., Dodge & Cox, and BlackRock, Inc. The MetLife Policyholder Trust also holds a substantial stake, with 16.17% of shares. Individual insider ownership accounts for a small percentage, around 0.25% to 0.9% of the stock.